Cadila Healthcare SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Cadila Healthcare analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Cadila Healthcare SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Cadila Healthcare to benchmark its business & performance as compared to the competitors and industry. As of 2020, Cadila Healthcare is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Cadila Healthcare competitors and includes Cadila Healthcare target market, segmentation, positioning & Unique Selling Proposition (USP).

Cadila Healthcare SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Cadila Healthcare Brand Analysis
Parent Company

Cadila Healthcare




Pharma and Healthcare

Tagline/ Slogan

The care continues


An integrated healthcare solutions provider, catering to over 45 therapeutic segments.

Cadila Healthcare STP
Cadila Healthcare Segmentation

Respiratory agents, cardiovascular, haematinics, gastrointestinal, analgesics, anti-infective and antibiotics, anti- diabetics and immunological.

Cadila Healthcare Target Market

Diagnostic, preventive and curative pharmaceutical and diagnostic product seeking healthcare professionals

Cadila Healthcare Positioning

Marketing of the pharma products to assuage, identify and thwart diseases.

Cadila Healthcare SWOT Analysis
Cadila Healthcare Strengths

Below are the Strengths in the SWOT Analysis of Cadila Healthcare:

1.USFDA approved plant for clinical trials

2.Sole manufacturer in Indian of Streptokinase and Hyaluronic Acid-based products

3. Caters to over 45 therapeutic areas and has presence in over 90 countries

4. Cadila has acquired Bio-chem which is major player in anti-infective segment in domestic market

5. Recommercialisation of Urokinase through partnership with Microbix

Cadila Healthcare Weaknesses

Here are the weaknesses in the Cadila Healthcare SWOT Analysis:

1. Tough competition means the market share is limted

2. Weak international presence compared to a few international brands

Cadila Healthcare Opportunities

Following are the Opportunities in Cadila Healthcare SWOT Analysis:

1. Large penetration strategies in the therapeutic market to increase the market share

2. increasing prevalence of chronic diseases such as diabetes, cancer

3. Penetration of medical insurance

Cadila Healthcare Threats

The threats in the SWOT Analysis of Cadila Healthcare are as mentioned:

1. Debt in the foreign currency and weak rupee may cause MTM

2. Economic fluctuations and emergence of global players
3. Govt policies and restrictions in the medical field

Cadila Healthcare Competition

Below are the top 5 Cadila Healthcare competitors:

1. Sun Pharma
2. Dr Reddys Labs

3. Cipla

4. Lupin

5. Ranbaxy

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Cadila Healthcare. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide

The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin